As of January 2025, Sinphar Pharmaceutical has a market cap of $150.80M. This makes Sinphar Pharmaceutical the world's 17762th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $166.19M | -4.57% |
2023 | $174.14M | 2.41% |
2022 | $170.04M | 14.71% |
2021 | $148.24M | -6.62% |
2020 | $158.75M | 59.54% |
2019 | $99.51M | 0.52% |
2018 | $99.00M | -10.85% |
2017 | $111.05M | -10.35% |
2016 | $123.87M | -12.03% |
2015 | $140.81M | -31.86% |
2014 | $206.65M | -8.21% |
2013 | $225.14M | 52.16% |
2012 | $147.96M | 35.85% |
2011 | $108.92M | -31.63% |
2010 | $159.30M | 14.68% |
2009 | $138.92M | 51.96% |
2008 | $91.42M | -21.69% |
2007 | $116.73M | 51.45% |
2006 | $77.08M | -11.54% |
2005 | $87.13M | 38.12% |
2004 | $63.09M | 13.87% |
2003 | $55.40M | 7.46% |
2002 | $51.56M | - |